-
EP3886882
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3886882
| EP3886882 - HAFNIA ALVEI FORMULATIONS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.09.2021 Database last updated on 24.08.2024 | |
| Former | The international publication has been made Status updated on 06.06.2020 | ||
| Former | unknown Status updated on 07.02.2020 | Most recent event Tooltip | 28.06.2024 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states Targedys 22 boulevard Gambetta 76000 Rouen / FR | For all designated states Centre Hospitalier Universitaire de Rouen 1, rue de Germont 76000 Rouen / FR | For all designated states INSERM (Institut National de la Santé et de la Recherche Médicale) 101 rue de Tolbiac 75654 Paris Cedex 13 / FR | For all designated states Université de Rouen 1, rue Thomas Becket 76130 Mont-Saint-Aignan / FR | [2021/40] | Inventor(s) | 01 /
PICOLO, Clémentine c/o TARGEDYS 22 boulevard Gambetta 76000 Rouen / FR | 02 /
LAMBERT, Grégory Les Murs Blancs 19 rue Henri Marrou 92290 Châtenay-Malabry / FR | 03 /
LEGRAND, Romain 31 rue Léon Delille 76800 Saint-Etienne-du-Rouvray / FR | 04 /
LUCAS, Nicolas 28 rue du Mont Gargan 76000 Rouen / FR | [2021/40] | Representative(s) | Icosa 83 avenue Denfert-Rochereau 75014 Paris / FR | [2021/40] | Application number, filing date | 19842780.9 | 28.11.2019 | [2021/40] | WO2019EP82949 | Priority number, date | EP20180208983 | 28.11.2018 Original published format: EP 18208983 | [2021/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020109490 | Date: | 04.06.2020 | Language: | EN | [2020/23] | Type: | A1 Application with search report | No.: | EP3886882 | Date: | 06.10.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.06.2020 takes the place of the publication of the European patent application. | [2021/40] | Search report(s) | International search report - published on: | EP | 04.06.2020 | Classification | IPC: | A61K35/74, A61K35/741, A23L33/00, A23L33/135, A61K9/20 | [2021/40] | CPC: |
A23L33/135 (EP,US);
A23L33/30 (EP,US);
A61K35/741 (EP,US);
A61K9/2063 (EP);
A61K9/485 (US);
A61K9/4858 (US);
| C-Set: |
A61K35/741, A61K2300/00 (EP);
A23V2002/00, A23V2200/3204, A23V2200/332, A23V2250/1586, A23V2250/161, A23V2250/1642, A23V2250/1886, A23V2250/5118 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/40] | Title | German: | HAFNIA-ALVEI-FORMULIERUNGEN | [2021/40] | English: | HAFNIA ALVEI FORMULATIONS | [2021/40] | French: | FORMULATIONS D'HAFNIA ALVEI | [2021/40] | Entry into regional phase | 28.06.2021 | National basic fee paid | 28.06.2021 | Designation fee(s) paid | 28.06.2021 | Examination fee paid | Examination procedure | 28.06.2021 | Examination requested [2021/40] | 28.06.2021 | Date on which the examining division has become responsible | 05.01.2022 | Amendment by applicant (claims and/or description) | 27.06.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time | Fees paid | Renewal fee | 28.10.2021 | Renewal fee patent year 03 | 24.11.2022 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.11.2023 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2014114805 (AGRONOMIQUE INST NAT RECH [FR], et al) [Y] 7-11,14,15 * paragraph [0042]; claim - *; | [YD]WO2016193829 (INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM) [FR], et al) [YD] 7-11,14,15 * claim - *; | [IDY]WO2017174658 (INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE) [FR], et al) [ID] 1-6,12,13 * page 17, line 14 - line 30 * * page 24, line 4 - page 26, line 7 * * page 30, line 13 - page 33, line 8; figures 15, 18-19; claim - * [Y] 7-11,14,15; | [YD]WO2018185080 (TARGEDYS [FR], et al) [YD] 7-11,14,15 * paragraph [0034] - paragraph [0035] * * paragraph [0140] ** paragraph [0166]; claim - * | by applicant | WO2016193829 | WO2017174658 | WO2018185080 | - PLOVIER et al., Nature Medicine, (20170000), vol. 23, no. 1, pages 107 - 113 | - NEEDLEMANWUNSCH, J. Mol. Biol., (19700000), vol. 48, pages 443 - 453 | - MOLLY, K.M. V. WOESTYNE et al., Applied Microbiology and Biotechnology, (19930000), vol. 39, pages 254 - 258 |